Cellectis S.A.
ALCLS.PA · PAR
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 93.3% | 85.5% | 81.1% | 100% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€0 | -€0 | -€0 | -€0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | €0 | -€0 | -€0 | -€0 |
| % Margin | 22.9% | -57.3% | -133.1% | -84% |
| Other Income/Exp. Net | -€0 | -€0 | -€0 | €0 |
| Pre-Tax Income | €0 | -€0 | -€0 | €0 |
| Tax Expense | €0 | -€0 | €0 | €0 |
| Net Income | €0 | -€0 | -€0 | €0 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS | 0.006 | -0.24 | -0.18 | 0.066 |
| % Growth | 102.5% | -33.3% | -373.1% | – |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.066 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €0 | -€0 | -€0 | €0 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |